Does the continuation of warfarin change management outcomes in epistaxis patients? - Wikidata - wikimedia - TriplyDB

Does the continuation of warfarin change management outcomes in epistaxis patients?

Does the continuation of warfarin change management outcomes in epistaxis patients?

http://www.wikidata.org/entity/Q38680374

about

Haematological factors in the management of adult epistaxis: systematic review.National audit of epistaxis management.

P2860

Q47217356-5E4D2A2B-D7ED-4399-98B7-200CAD081B2E Q49560520-79ABD8BB-72F7-4F78-B015-01706AC0E010

P2860

Does the continuation of warfarin change management outcomes in epistaxis patients?

http://www.wikidata.org/entity/Q38680374

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Does the continuation of warfarin change management outcomes in epistaxis patients?

@en

type

label

Does the continuation of warfarin change management outcomes in epistaxis patients?

@en

prefLabel

Does the continuation of warfarin change management outcomes in epistaxis patients?

@en

P1433

Q38680374-914532EE-F2CF-4310-A13B-9A3A8C1D4CE5

P1476

Q38680374-39A283E2-0921-48A8-8C3A-D29A2B4A579B

P2093

Q38680374-699AFD1A-E40B-4F61-BED2-634DF5C4A8B9

Q38680374-7837C924-48C5-41BD-A38A-E14D4B1D1368

Q38680374-82F89C0F-BC5B-434F-8ED7-CEFB0FBEF589

Q38680374-94A12C5C-49A5-4EDA-8A47-82622866E483

Q38680374-D2CEC37E-209C-4212-8957-B1398412C2D4

P2860

Q38680374-11748F59-CB31-4E1E-825F-55B6BAC81676

Q38680374-441E1F22-FC87-4BD2-8138-7C78755D73C0

Q38680374-56AFD72E-5C2F-4AFC-9F07-BC780E4E33F8

Q38680374-709EF804-1DF6-40F3-B899-6EDF63DA2622

Q38680374-7490F3A4-9AD9-4BA7-ACA1-113C35C2750D

Q38680374-93F38E76-81E4-46F8-B51D-322318A7E44E

Q38680374-F3ECBA13-D274-4DC6-9045-AD580F8317C6

P304

Q38680374-B7FCDD09-7577-4FC3-96DA-E21EE1DD24E8

P31

Q38680374-0ADB298A-FCAE-464C-9CAC-EA625A5FB532

P356

Q38680374-6E31C950-B2F0-4E86-B790-20C4AF6A7102

P433

Q38680374-FF42DEAB-D252-465E-82B9-7AA9EC775E71

P478

Q38680374-7BF9D937-8246-462E-AD60-1B588C6AD949

P577

Q38680374-AF5E1BCF-8E0E-4E28-893D-DDABE5497F3F

P698

Q38680374-0E708F19-84E0-45B8-90D8-29D6027E4A54

P921

Q38680374-49FB2983-D8AA-4B3D-A3FA-CF7FE2ED9C4A

P356

S0022215115003424

P1433

The Journal of Laryngology & Otology

P1476

Does the continuation of warfarin change management outcomes in epistaxis patients?

@en

P2093

C Potter

http://www.w3.org/2001/XMLSchema#string

R Marsh

http://www.w3.org/2001/XMLSchema#string

S Bola

http://www.w3.org/2001/XMLSchema#string

S Braggins

http://www.w3.org/2001/XMLSchema#string

S Hickey

http://www.w3.org/2001/XMLSchema#string

P2860

Warfarin: almost 60 years old and still causing problems

Endonasal laser dacryocystorhinostomy: its role in anticoagulated patients.

Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.

Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study.

Cost-effectiveness of endoscopic sphenopalatine artery ligation versus nasal packing as first-line treatment for posterior epistaxis.

Treatment algorithm for oral anticoagulant and antiplatelet therapy in epistaxis patients.

Cost-effectiveness analysis of endoscopic sphenopalatine artery ligation vs arterial embolization for intractable epistaxis.

P304

256-260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0022215115003424

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26707504

http://www.w3.org/2001/XMLSchema#string

P921